Sidebar

  • Magazine
  • Events
  • Videos
  • Gallery
  • Blog
  • Gantry Home

Magazine menu

  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
The Power of Truth®
Sunday, May 18, 2025
Sunday, May 18, 2025
  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
  1. You are here:  
  2. Health

Cell-based therapy improves outcomes in a pig model of heart attacks

Details
Staff logo
08 January 2025
Health
  • Previous Article Glass of milk a day cuts bowel cancer risk - study
  • Next Article Ketamine use on the rise in U.S. adults; new trends emerge
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that overexpress cyclin D2 and are knocked out for human leukocyte antigen classes I and II. This research used a pig model of heart attacks.
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that overexpress cyclin D2 and are knocked out for human leukocyte antigen classes I and II. This research used a pig model of heart attacks.

Read more https://www.sciencedaily.com/releases/2025/01/250107194106.htm

  • Previous Article Glass of milk a day cuts bowel cancer risk - study
  • Next Article Ketamine use on the rise in U.S. adults; new trends emerge

HUNGRY FOR TRUTH?  FEED THE NEED.

The Power of Truth®
  • Cookies Policy
  • Privacy Policy
  • Terms of Use
  • Contact
Copyright © 2025 Joomla!. All Rights Reserved. Powered by The Power of Truth® - Designed by JoomlArt.com. Bootstrap is a front-end framework of Twitter, Inc. Code licensed under Apache License v2.0. Font Awesome font licensed under SIL OFL 1.1.